Insulin Receptor Signaling in the β-Cell Influences Insulin Gene Expression and Insulin Content: Evidence for Autocrine β-Cell Regulation

The insulin receptor (IR) is expressed by insulin-secreting β-Cells, but its cellular function is unknown. We transfected βTC6-F7 β-Cells with cDNAs encoding either wild-type or mutant kinase-inactive (A/K1018) IRs, and by fluorescence-activated cell sorting generated polyclonal β-cell lines that overexpressed each receptor type at levels two- to fourfold higher than the parental cells. β-Cells overexpressing wild-type IRs had a proportional increase in insulin-stimulated tyrosine kinase activity; no change occurred in β-Cells expressing the mutant IR. We observed a threefold increase in cellular insulin content in β-Cells that overexpressed the wildtype IR, as determined by radioimmunoassay. This increase occurred despite a fivefold elevated rate of both basal and 10 mmol/l glucose-induced insulin secretion. Fractional insulin secretion (percentage of total cell insulin releasable at 10 mmol/l glucose) was unchanged in β-Cells overexpressing the wild-type IR compared with the parental β-cell line. Insulin content and insulin secretion were unaffected by overexpression of kinase-inactive IRs. Steady-state insulin mRNA levels were elevated twofold in the β-Cells overexpressing the wild-type IR and unchanged in the β-Cells expressing the kinase-inactive receptor, as determined by Northern blot analysis. The rate of insulin mRNA degradation measured in the presence of 5 μg/ml actinomycin D was not significantly affected in either cell line. In the absence of glucose, the basal level of (pro)insulin biosynthesis in the β-Cells overexpressing the wild-type IR increased significantly (61%) compared with the pcells transfected with the kinase-inactive IR. These data indicate that IR signaling can regulate insulin gene transcription and can modulate the steady-state insulin content of β-Cells.

[1]  G. Shulman,et al.  Disruption of IRS-2 causes type 2 diabetes in mice , 1998, Nature.

[2]  C. Newgard,et al.  Regulation of Insulin Secretion From Novel Engineered Insulinoma Cell Lines , 1997, Diabetes.

[3]  C. Kahn,et al.  Development of a Novel Polygenic Model of NIDDM in Mice Heterozygous for IR and IRS-1 Null Alleles , 1997, Cell.

[4]  B. Wolf,et al.  Wortmannin Inhibits Insulin Secretion in Pancreatic Islets and β-TC3 Cells Independent of Its Inhibition of Phosphatidylinositol 3-Kinase , 1996, Diabetes.

[5]  B. Wolf,et al.  Expression of Insulin Receptor mRNA and Insulin Receptor Substrate 1 in Pancreatic Islet β-Cells , 1996, Diabetes.

[6]  J. Holst,et al.  Potent inhibitory effects of transplantable rat glucagonomas and insulinomas on the respective endogenous islet cells are associated with pancreatic apoptosis. , 1995, The Journal of clinical investigation.

[7]  B. Wolf,et al.  Glucose-Induced Insulin Receptor Tyrosine Phosphorylation in Insulin-Secreting β-Cells , 1995, Diabetes.

[8]  E. Verspohl,et al.  Role of tyrosine kinase in insulin release in an insulin secreting cell line (INS-1). , 1995, Cellular signalling.

[9]  H. Benecke,et al.  Impaired Insulin Signaling in Skeletal Muscles from Transgenic Mice Expressing Kinase-deficient Insulin Receptors (*) , 1995, The Journal of Biological Chemistry.

[10]  M. Stampfer,et al.  Insulin receptor overexpression in 184B5 human mammary epithelial cells induces a ligand‐dependent transformed phenotype , 1995, Journal of cellular biochemistry.

[11]  B. Wolf,et al.  Identification of phosphatidylinositol 3,4,5-trisphosphate in pancreatic islets and insulin-secreting beta-cells. , 1995, Biochemical and biophysical research communications.

[12]  S. Efrat,et al.  Clonal Insulinoma Cell Line That Stably Maintains Correct Glucose Responsiveness , 1994, Diabetes.

[13]  Y. Le Marchand-Brustel,et al.  Expression of a dominant-negative mutant human insulin receptor in the muscle of transgenic mice. , 1994, The Journal of biological chemistry.

[14]  J. Olefsky,et al.  Hybrid formation between endogenous mouse and transfected human tyrosine kinase-deficient (A/K1018) insulin receptors leads to decreased insulin sensitivity in 3T3-L1 adipocytes. , 1994, Molecular endocrinology.

[15]  C. Kahn,et al.  The level of insulin receptor tyrosine kinase activity modulates the activities of phosphatidylinositol 3-kinase, microtubule-associated protein, and S6 kinases. , 1994, Molecular endocrinology.

[16]  J. Olefsky,et al.  Shc is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and p21ras-GTP formation. , 1994, The Journal of biological chemistry.

[17]  R. Sorenson,et al.  Effect of tyrosine kinase inhibitors on islets of Langerhans: evidence for tyrosine kinases in the regulation of insulin secretion. , 1994, Endocrinology.

[18]  H. Towle,et al.  Regulation of Human Insulin Gene Transcription by Glucose, Epinephrine, and Somatostatin , 1994, Diabetes.

[19]  T. Okada,et al.  Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. , 1994, The Journal of biological chemistry.

[20]  D. Accili,et al.  Investigation of the mechanism of the dominant negative effect of mutations in the tyrosine kinase domain of the insulin receptor. , 1994, The EMBO journal.

[21]  C. Kahn,et al.  The insulin signaling system. , 1994, The Journal of biological chemistry.

[22]  E. D. de Koning,et al.  Molecular physiology of the islet amyloid polypeptide (IAPP)/amylin gene in man, rat, and transgenic mice , 1994, Journal of cellular biochemistry.

[23]  Y. Nonomura,et al.  Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. , 1993, The Journal of biological chemistry.

[24]  C. Kahn,et al.  Human Skeletal Muscle Insulin Receptor Substrate-1: Characterization of the cDNA, Gene, and Chromosomal Localization , 1993, Diabetes.

[25]  Nanxin Li,et al.  The function of GRB2 in linking the insulin receptor to Ras signaling pathways. , 1993, Science.

[26]  R. Roth,et al.  Identification of SHC as a substrate of the insulin receptor kinase distinct from the GAP-associated 62 kDa tyrosine phosphoprotein. , 1993, Biochemical and biophysical research communications.

[27]  A. Ullrich,et al.  The SH2/SH3 domain‐containing protein GRB2 interacts with tyrosine‐phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. , 1993, The EMBO journal.

[28]  M. White,et al.  The New Elements of Insulin Signaling: Insulin Receptor Substrate-1 and Proteins With SH2 Domains , 1993, Diabetes.

[29]  R. Aebersold,et al.  The insulin-elicited 160 kDa phosphotyrosine protein in mouse adipocytes is an insulin receptor substrate 1: identification by cloning. , 1993, Biochimica et biophysica acta.

[30]  T. Pawson,et al.  Insulin-induced phosphorylation of the 46- and 52-kDa Shc proteins. , 1993, The Journal of biological chemistry.

[31]  H. Zühlke,et al.  In vitro effect of vanadate on content, secretion and biosynthesis of insulin in isolated islets of normal Wistar rats. , 2009, Experimental and clinical endocrinology.

[32]  K. Siddle,et al.  A monoclonal anti-peptide antibody reacting with the insulin receptor beta-subunit. Characterization of the antibody and its epitope and use in immunoaffinity purification of intact receptors. , 1992, The Biochemical journal.

[33]  J. Wands,et al.  Cloning and increased expression of an insulin receptor substrate-1-like gene in human hepatocellular carcinoma. , 1992, Biochemical and biophysical research communications.

[34]  M. Permutt,et al.  Feedback inhibition of insulin gene expression by insulin. , 1992, The Journal of clinical investigation.

[35]  C. Kahn,et al.  Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein , 1991, Nature.

[36]  A. Costantino,et al.  Overexpression of insulin receptors in fibroblast and ovary cells induces a ligand-mediated transformed phenotype. , 1991, Molecular endocrinology.

[37]  E. Verspohl,et al.  Indirect evidence for short-loop negative feedback of insulin secretion in the rat. , 1991, The Journal of endocrinology.

[38]  P. Leder,et al.  The cytomegalovirus enhancer: a pan-active control element in transgenic mice , 1990, Molecular and cellular biology.

[39]  J. Olefsky,et al.  The ligand binding characteristics of a kinase-defective A/K1018 human insulin receptor expressed in Rat 1 fibroblasts. , 1990, Biochimica et biophysica acta.

[40]  K. Siddle,et al.  Identification of epitopes on the human insulin receptor reacting with rabbit polyclonal antisera and mouse monoclonal antibodies. , 1990, The Journal of biological chemistry.

[41]  J. Leahy,et al.  Insulin-like growth factor-I at physiological concentrations is a potent inhibitor of insulin secretion. , 1990, Endocrinology.

[42]  R. Roth,et al.  Insulin receptor structure and function in normal and pathological conditions. , 1990, Annual review of medicine.

[43]  D. Pipeleers,et al.  Glucose stimulates proinsulin biosynthesis by a dose-dependent recruitment of pancreatic beta cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[44]  S. Bonner-Weir Morphological Evidence for Pancreatic Polarity of β-Cell Within Islets of Langerhans , 1988, Diabetes.

[45]  T. Dull,et al.  A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis. , 1987, The Journal of biological chemistry.

[46]  O. Rosen After insulin binds. , 1987, Science.

[47]  H. Klein,et al.  Insulin activation of insulin receptor tyrosine kinase in intact rat adipocytes. An in vitro system to measure histone kinase activity of insulin receptors activated in vivo. , 1986, The Journal of biological chemistry.

[48]  D. Morgan,et al.  Mapping surface structures of the human insulin receptor with monoclonal antibodies: localization of main immunogenic regions to the receptor kinase domain. , 1986, Biochemistry.

[49]  B. Draznin,et al.  Feedback inhibition of insulin on insulin secretion in isolated pancreatic islets. , 1986, Endocrinology.

[50]  D. Steiner,et al.  Control of insulin gene expression in pancreatic beta-cells and in an insulin-producing cell line, RIN-5F cells. II. Regulation of insulin mRNA stability. , 1985, The Journal of biological chemistry.

[51]  G. Grunberger,et al.  Use of tyrosine-containing polymers to characterize the substrate specificity of insulin and other hormone-stimulated tyrosine kinases. , 1985, European journal of biochemistry.

[52]  J. Olefsky,et al.  Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus. , 1985, The Journal of clinical endocrinology and metabolism.

[53]  C. Kahn The molecular mechanism of insulin action. , 1985, Annual review of medicine.

[54]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[55]  C. Kahn,et al.  Characterization of the insulin receptor kinase purified from human placental membranes. , 1983, The Journal of biological chemistry.

[56]  O. Rosen,et al.  Phosphorylation of exogenous substrates by the insulin receptor-associated protein kinase. , 1983, The Journal of biological chemistry.

[57]  C. Kahn,et al.  Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system , 1982, Nature.

[58]  T. W. James,et al.  Assay for nanogram quantities of DNA in cellular homogenates. , 1979, Analytical biochemistry.

[59]  U. Keller,et al.  Inhibition of Insulin Secretion by Exogenous Insulin in Normal Man as Demonstrated by C-peptide Assay , 1978, Diabetes.

[60]  E. Verspohl,et al.  Pyridine nucleotides in pancreatic islets during inhibition of insulin release by exogenous insulin. , 1976, Endocrinology.

[61]  A. Rappaport,et al.  Effects on insulin output and on pancreatic blood flow of exogenous insulin infusion into an in situ isolated portion of the pancreas. , 1972, Endocrinology.

[62]  J. Iversen,et al.  Evidence for a Feedback Inhibition of Insulin on Insulin Secretion in the Isolated, Perfused Canine Pancreas , 1971, Diabetes.

[63]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[64]  J. Sodoyez,et al.  Evidence for an Insulin-Induced Inhibition of Insulin Release by Isolated Islets of Langerhans∗ , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.